4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-22-011119
Chairman and CEO bought 7,500 shares at an average $1.44 ($10,765)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2022-02-16 | Purchase | +1,000 | $1.47 | $1,470 | 11,207,406 | D |
| Niihara Yutaka Chairman and CEO | 2022-02-17 | Purchase | +6,500 | $1.43 | $9,295 | 11,213,906 | D |
| Open-market purchases · 7,500 sh · avg $1.44 · $10,765 | |||||||
Loading xslF345X03/doc4.xml…